The Effect Of Platelet Rich Fibrin on Implant Stability
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Dental Implant
- Sponsor
- ELİF ONCU
- Enrollment
- 20
- Locations
- 1
- Primary Endpoint
- Implant Stabilitty Quotient (ISQ) evaluation: analysis of the resonance frequency values 4 week period.
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
The purpose of this study was to evaluate the effects of (Platelet Rich Fibrin) PRF application on implant osseointegration in the early phase of healing.
Detailed Description
Objectives:Achieving accelerated implant osseointegration could provide immediate or early loading of implants. Platelet-rich fibrin (PRF) is widely used to accelerate soft and hard tissue healing. Activated platelets in PRF release growth factors resulting in cellular proliferation, collagen synthesis and osteoid production. The aim of this study was to compare the stability of dental implants inserted with one-stage surgical protocol with or without PRF application. Design: Non-randomized, Active Controlled Trial. Material and Methods: Twenty healthy patients (n=10 test group, n= control group) with adequate alveolar bone, having 2 or more adjacent missing teeth, extracted at least 6 months ago were included in this study. Minimum two tapered implants (Ankylosis, DentsplyFriadent) were placed to each patient. After surgical preparation of implant sockets, PRF that was prepared preoperatively was placed randomly to one of the sockets (PRF+). Acellular plasma portion of PRF was used to wet the implant placed into the PRF-coated socket. Resonance frequency measurements were made by Osstell ISQ after placement of implants, at 1 week and one month postoperatively. Key Words: Dental implant stability, Platelet Rich Fibrin, Resonance frequency analysis
Investigators
ELİF ONCU
Assist.Prof.Dr.
Necmettin Erbakan University
Eligibility Criteria
Inclusion Criteria
- •The absence of any lesions in the oral cavity, and sufficient residual bone volume to receive two or more adjacent implants of ≥3.5 mm in diameter and 11.0 mm in length, and extracted at least 6 months ago.
Exclusion Criteria
- •Insufficient bone volume
- •Parafunctional habits
- •Smoking more than 10 cigarettes per day
- •Excessive consumption of alcohol
- •Localized radiotherapy of the oral cavity
- •Antitumor chemotherapy
- •Liver, blood, and kidney diseases
- •Immunosuppression
- •Current corticosteroid or bisphosphonate use
- •Pregnancy
Outcomes
Primary Outcomes
Implant Stabilitty Quotient (ISQ) evaluation: analysis of the resonance frequency values 4 week period.
Time Frame: Resonance frequency measurements were made by Osstell ISQ after placement of implants, at 1 week and one month postoperatively.
The stability of the implants were evaluated with the resonance frequency analysis (RFA) method. The measurements were carried out with Osstell ISQ (Implant Stability Quotient) (Osstell, Göteborg, Sweden) by connecting the transducer (smartpeg) to the implant. Two mesio-distal and bucco-lingual measurements were recorded and mean ISQ values were calculated. The resonance frequency measurements were repeated at first and fourth weeks.
Secondary Outcomes
- Evaluation of osseointegration in different types of bone(Resonance frequency measurements in different bone types were made by Osstell ISQ after placement of implants, at 1 week and one month postoperatively.)